MLAB · CIK 0000724004 · operating
Mesa Laboratories develops and manufactures quality control and life sciences tools for pharmaceutical, medical device, and healthcare industries across North America, Europe, Asia Pacific, and other markets. The company operates through four primary segments serving distinct customer needs in sterilization validation, genetic analysis, biopharmaceutical development, and calibration.
The Sterilization and Disinfection Control segment produces biological, chemical, and cleaning indicators that assess the effectiveness of sterilization, decontamination, disinfection, and cleaning processes. The Clinical Genomics segment offers the MassARRAY genetic analysis platform and related consumables used by clinical laboratories for disease testing, pharmacogenetics, oncology analysis, and infectious disease screening. The Biopharmaceutical Development segment provides automated systems for protein and peptide analysis, including the Gyrolab platform hardware and consumables, as well as peptide synthesis and purification instruments. The Calibration Solutions segment supplies quality control products for environmental monitoring, dialysis, gas flow, air quality, and torque testing applications, marketed under brands including DialyGuard, ViewPoint, DataTrace, and DryCal.
The company operates with approximately 730 full-time employees and maintains manufacturing and service capabilities to support its diverse customer base. Mesa Laboratories was incorporated in Colorado in 1982 and remains headquartered in Lakewood, Colorado.
Fiscal years are as reported by the company and may not align with the calendar year. For example, Apple's FY 2024 ends in September 2024.
| Fiscal Year | EPS Diluted | EPS Basic | YoY | |
|---|---|---|---|---|
| 2025 | $-0.36 | $-0.36 | +99.2% | |
| 2024 | $-47.20 | $-47.20 | -27864.7% | |
| 2023 | $0.17 | $0.17 | -51.4% | |
| 2022 | $0.35 | $0.36 | -52.7% | |
| 2021 | $0.74 | $0.76 | +300.0% | |
| 2020 | $-0.37 | $-0.38 | -208.8% | |
| 2019 | $0.34 | $0.36 | +143.0% | |
| 2018 | $-0.79 | $1.12 | -127.1% | |
| 2017 | $2.91 | $0.98 | -2.0% | |
| 2016 | $2.97 | $1.10 | +12.9% | |
| 2015 | $2.63 | $0.63 | +176.8% | |
| 2014 | $0.95 | $1.00 | +33.8% | |
| 2012 | $0.71 | $0.76 | -69.0% | |
| 2011 | $2.29 | $2.41 | — |
| Report Date | Filed | Accession Number | |
|---|---|---|---|
| 2025-03-31 | 2025-05-28 | 0001437749-25-018586 | SEC ↗ |
| 2024-03-31 | 2024-06-28 | 0001437749-24-021606 | SEC ↗ |
| 2023-03-31 | 2023-05-30 | 0001437749-23-016028 | SEC ↗ |
| 2022-03-31 | 2022-05-31 | 0001437749-22-013906 | SEC ↗ |
| 2021-03-31 | 2021-06-01 | 0001437749-21-013801 | SEC ↗ |
| 2020-03-31 | 2020-06-01 | 0001437749-20-012142 | SEC ↗ |
| 2019-03-31 | 2019-06-03 | 0001437749-19-011234 | SEC ↗ |
| 2018-03-31 | 2018-06-05 | 0001437749-18-011240 | SEC ↗ |
| 2017-03-31 | 2017-06-07 | 0001437749-17-010820 | SEC ↗ |
| 2016-03-31 | 2016-06-06 | 0001437749-16-033334 | SEC ↗ |
| 2015-03-31 | 2015-06-03 | 0001437749-15-011723 | SEC ↗ |
| 2014-03-31 | 2014-06-04 | 0001437749-14-010696 | SEC ↗ |
| 2013-03-31 | 2013-06-06 | 0001104659-13-047358 | SEC ↗ |
| 2012-03-31 | 2012-06-29 | 0001104659-12-046862 | SEC ↗ |
| 2011-03-31 | 2011-06-29 | 0001104659-11-037127 | SEC ↗ |
| 2010-03-31 | 2010-06-29 | 0001104659-10-036198 | SEC ↗ |